EZH2 and neoplasm: Strikingly, both NK or CD8+ T cell depletion mitigated long-term survival and prevented complete tumor responses induced following T/P treatment of animals with EZH2 suppressed KPC1 and KPC2 PDAC tumors (Fig. 5h,i and Extended Data Fig. 7h).